Longitudinal trends in HbA1c patterns and association with outcomes: A systematic review

Miyang Luo, Kristin Hui Xian Tan, Chuen Seng Tan, Wei Yen Lim, E-Shyong Tai, Kavita Venkataraman, Miyang Luo, Kristin Hui Xian Tan, Chuen Seng Tan, Wei Yen Lim, E-Shyong Tai, Kavita Venkataraman

Abstract

Background: This study aimed to review studies that identified patterns of longitudinal HbA1c trends in patients with diabetes and to summarize factors and outcomes associated with distinct trajectory patterns.

Methods: PubMed and Web of Science were systematically searched for studies examining HbA1c trends among patients with diabetes from database inception through September 2017. Articles were included if they met the following inclusion criteria: (a) longitudinal study of subjects with diabetes only, (b) use of serial measurements of HbA1c , and (c) analysis of the trend of HbA1c using group-based trajectory approaches.

Results: Twenty studies were included, 11 on type 1 diabetes and 9 on type 2 diabetes. These studies identified 2 to 6 HbA1c trajectory patterns. The most commonly identified patterns included stable HbA1c around 7.0% and at levels between 8.0% and 9.9%, which usually captured the HbA1c pattern among the majority of subjects in the study population. Unstable patterns identified included increasing HbA1c trend, decreasing HbA1c trend, and non-linear patterns. These patterns were associated with differential risk of disease outcomes, over and beyond single-point HbA1c measures. Age, gender, ethnicity, diabetes duration, disease management frequency, cardiovascular risk factors, insulin treatment, family environment, and psychosocial factors were the most frequently reported factors associated with membership of specific HbA1c pattern groups.

Conclusion: Common patterns of longitudinal HbA1c trends were identified despite heterogeneity among the studies. A better understanding of what underlies these different patterns may provide opportunities to tailor therapies and care for these patients to reduce adverse outcomes.

Keywords: HbA1c; diabetes-related outcomes; glycaemic control; group-based trajectory analysis; longitudinal trends.

© 2018 The Authors. Diabetes/Metabolism Research and Reviews Published by John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Flowchart of study selection process

References

    1. American Diabetes Association. 5. Glycemic Targets . Standards of medical care in diabetes. Diabetes Care. 2016;S39‐S46.
    1. Group UKPDS . Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet. 1998;352(9131):837‐853.
    1. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560‐2572.
    1. Svoren BM, Volkening LK, Butler DA, Moreland EC, Anderson BJ, Laffel LMB. Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes. J Pediatr. 2007;150(3):279‐285.
    1. Hsu CC, Chang HY, Huang MC, et al. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7‐year prospective cohort study. Diabetologia. 2012;55(12):3163‐3172.
    1. Gorst C, Kwok CS, Aslam S, et al. Long‐term glycemic variability and risk of adverse outcomes: a systematic review and meta‐analysis. Diabetes Care. 2015;38(12):2354‐2369.
    1. Nichols GA, Joshua‐Gotlib S, Parasuraman S. Glycemic control and risk of cardiovascular disease hospitalization and all‐cause mortality. J Am Coll Cardiol. 2013;62(2):121‐127.
    1. Gebregziabher M, Egede LE, Lynch CP, Echols C, Zhao Y. Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach. Am J Epidemiol. 2010;171(10):1090‐1098.
    1. Nagin DS, Odgers CL. Group‐based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6(1):109‐138.
    1. Twisk J, Hoekstra T. Classifying developmental trajectories over time should be done with great caution: a comparison between methods. J Clin Epidemiol. 2012;65(10):1078‐1087.
    1. Musliner KL, Munk‐Olsen T, Eaton WW, Zandi PP. Heterogeneity in long‐term trajectories of depressive symptoms: patterns, predictors and outcomes. J Affect Disord. 2016;192:199‐211.
    1. Piquero AR. Taking stock of developmental trajectories of criminal activity over the life course In: Liberman AM, ed. The Long View of Crime: A Synthesis of Longitudinal Research. New York, NY: Springer; 2008:23‐78.
    1. Luo M, Tan H, Lim W. HbA1c trajectories and outcome among diabetes patients. Available from
    1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical Research Ed). 2009;b2700:339.
    1. Standards of medical care in diabetes—2017: summary of revisions. Diabetes Care 2017;40(Supplement 1):S4‐S5.
    1. Stang A. Critical evaluation of the Newcastle‐Ottawa scale for the assessment of the quality of nonrandomized studies in meta‐analyses. Eur J Epidemiol. 2010;25(9):603‐605.
    1. Wells GA SB, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle‐Ottawa Scale (NOS) For assessing the quality of nonrandomised studies in meta‐analyses 2014 [8 June 2015]. Available from: main file with tracked change kv.docx.
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. International Journal of Surgery (London, England). 2014;12(12):1495‐1499.
    1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7). e1000100
    1. Rohan JM, Rausch JR, Pendley JS, et al. Identification and prediction of group‐based glycemic control trajectories during the transition to adolescence. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 2014;33(10):1143‐1152.
    1. Phan TL, Hossain J, Lawless S, Werk LN. Quarterly visits with glycated hemoglobin monitoring: the sweet spot for glycemic control in youth with type 1 diabetes. Diabetes Care. 2014;37(2):341‐345.
    1. Monaghan M, King MM, Alvarez V, Cogen FR, Wang J. Changes in type 1 diabetes health indicators from high school to college. J Am Coll Health. 2016;64(2):157‐161.
    1. King PS, Berg CA, Butner J, et al. Longitudinal trajectories of metabolic control across adolescence: associations with parental involvement, adolescents' psychosocial maturity, and health care utilization. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine. 2012;50(5):491‐496.
    1. Chang HY, Wahlqvist ML, Liu WL, et al. Management trajectories in the type 2 diabetes integrated delivery system project in Taiwan: accounting for behavioral therapy, nutrition education and therapeutics. Asia Pac J Clin Nutr. 2014;23(4):592‐606.
    1. Laiteerapong N, Karter AJ, Moffet HH, et al. Ten‐year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: the Diabetes & Aging Study. J Diabetes Complications. 2017;31(1):94‐100.
    1. Walraven I, Mast MR, Hoekstra T, et al. Distinct HbA1c trajectories in a type 2 diabetes cohort. Acta Diabetol. 2015;52(2):267‐275.
    1. Luo M, Lim WY, Tan CS, et al. Longitudinal trends in HbA1c and associations with comorbidity and all‐cause mortality in Asian patients with type 2 diabetes: a cohort study. Diabetes Res Clin Pract. 2017;133:69‐77.
    1. Bayliss EA, Blatchford PJ, Newcomer SR, Steiner JF, Fairclough DL. The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control. J Gen Intern Med. 2011;26(6):575‐581.
    1. Control TD, Group CTR . The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. New England Journal of Medicine. 1993;329(14):977‐986.
    1. Marshall SL, Edidin DV, Arena VC, et al. Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education. Diabetes Res Clin Pract. 2015;107(1):113‐122.
    1. Factors influencing glycemic control in young people with type 1 diabetes in Scotland: a population‐based study (DIABAUD2). Diabetes care. 2001;24(2):239‐244.
    1. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LM. Predictors of glycemic control and short‐term adverse outcomes in youth with type 1 diabetes. J Pediatr. 2001;139(2):197‐203.
    1. Frey MA, Templin T, Ellis D, Gutai J, Podolski CL. Predicting metabolic control in the first 5 yr after diagnosis for youths with type 1 diabetes: the role of ethnicity and family structure. Pediatr Diabetes. 2007;8(4):220‐227.
    1. Petitti DB, Klingensmith GJ, Bell RA, et al. Glycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study. The Journal of Pediatrics. 2009;155(5):668‐672.e661‐663.
    1. Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12(1):11‐17.
    1. Kim H, Elmi A, Henderson CL, Cogen FR, Kaplowitz PB. Characteristics of children with type 1 diabetes and persistent suboptimal glycemic control. J Clin Res Pediatr Endocrinol. 2012;4(2):82‐88.
    1. Zuijdwijk CS, Cuerden M, Mahmud FH. Social determinants of health on glycemic control in pediatric type 1 diabetes. J Pediatr. 2013;162(4):730‐735.
    1. Sherr JL, Hermann JM, Campbell F, et al. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia. 2016;59(1):87‐91.
    1. Hassan K, Loar R, Anderson BJ, Heptulla RA. The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr. 2006;149(4):526‐531.
    1. Ellis DA, Podolski CL, Frey M, Naar‐King S, Wang B, Moltz K. The role of parental monitoring in adolescent health outcomes: impact on regimen adherence in youth with type 1 diabetes. J Pediatr Psychol. 2007;32(8):907‐917.
    1. Butler DA, Zuehlke JB, Tovar A, Volkening LK, Anderson BJ, Laffel LM. The impact of modifiable family factors on glycemic control among youth with type 1 diabetes. Pediatr Diabetes. 2008;9(4 Pt 2):373‐381.
    1. Duke DC, Geffken GR, Lewin AB, Williams LB, Storch EA, Silverstein JH. Glycemic control in youth with type 1 diabetes: family predictors and mediators. J Pediatr Psychol. 2008;33(7):719‐727.
    1. Helgeson VS, Palladino DK. Implications of psychosocial factors for diabetes outcomes among children with type 1 diabetes: a review. Social and Personality Psychology Compass. 2012;6(3):228‐242.
    1. Viner RM, White B, Amin R, et al. Impact of deprivation, ethnicity, and insulin pump therapy on developmental trajectories of diabetes control in COB type 1 diabetes. Pediatr Diabetes. 2016.
    1. Schwandt A, Hermann JM, Rosenbauer J, et al. Longitudinal trajectories of metabolic control from childhood to young adulthood in type 1 diabetes from a large German/Austrian Registry: a group‐based modeling approach. Diabetes care. 2017;40(3):309‐316.
    1. Misra R, Lager J. Ethnic and gender differences in psychosocial factors, glycemic control, and quality of life among adult type 2 diabetic patients. J Diabetes Complications. 2009;23(1):54‐64.
    1. Benoit SR, Fleming R, Philis‐Tsimikas A, Ji M. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health. 2005;5(1):36.
    1. de Rekeneire N, Rooks RN, Simonsick EM, et al. Racial differences in glycemic control in a well‐functioning older diabetic population. Findings from the Health, Aging and Body Composition study. 2003;26(7):1986‐1992.
    1. Khattab M, Khader YS, Al‐Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010;24(2):84‐89.
    1. Richardson LK, Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes. Gen Hosp Psychiatry. 2008;30(6):509‐514.
    1. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2004;27(3):752‐757.
    1. Keating NL, Zaslavsky AM, Herrinton LJ, Selby JV, Wolf RE, Ayanian JZ. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007;45(9):869‐875.
    1. Leong KS, Wilding JP. Obesity and diabetes. Best Pract Res Clin Endocrinol Metab. 1999;13(2):221‐237.
    1. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England). 1998;352(9131):837‐853.
    1. Luyckx K, Seiffge‐Krenke I. Continuity and change in glycemic control trajectories from adolescence to emerging adulthood: relationships with family climate and self‐concept in type 1 diabetes. Diabetes Care. 2009;32(5):797‐801.
    1. Hilliard ME, Wu YP, Rausch J, Dolan LM, Hood KK. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine. 2013;52(1):28‐34.
    1. Wang CP, Hazuda HP. Better glycemic control is associated with maintenance of lower‐extremity function over time in Mexican American and European American older adults with diabetes. Diabetes Care. 2011;34(2):268‐273.
    1. Helgeson VS, Snyder PR, Seltman H, Escobar O, Becker D, Siminerio L. Brief report: trajectories of glycemic control over early to middle adolescence. J Pediatr Psychol. 2010;35(10):1161‐1167.
    1. Migliore CL, Vorderstrasse A, Pan W, Melkus GD. Renal disease risk factors among risk groups comprised of African American women with type 2 diabetes: a secondary analysis. Diabetes Educ. 2015;41(5):569‐581.
    1. Lawes T, Franklin V, Farmer G. HbA1c tracking and bio‐psychosocial determinants of glycaemic control in children and adolescents with type 1 diabetes: retrospective cohort study and multilevel analysis. Pediatr Diabetes. 2014;15(5):372‐383.
    1. Mast MR, Walraven I, Hoekstra T, et al. Effectiveness of insulin therapy in people with type 2 diabetes in the Hoorn Diabetes Care System. Diabetic Medicine : A Journal of the British Diabetic Association. 2016;33(6):794‐802.
    1. Ravona‐Springer R, Heymann A, Schmeidler J, et al. Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. PLoS One. 2014;9(6):e97384.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner